NCT04453904View on ClinicalTrials.gov

Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer

NARecruitingINTERVENTIONAL
Enrollment

654

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2027

Conditions
Endometrial Cancer
Interventions
OTHER

"sequential radiochemotherapy in a sanwich mode"

Patients will randomized into two different modalities of radiochemotherapy.

Trial Locations (1)

100044

RECRUITING

Jianliu Wang, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT04453904 - Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer | Biotech Hunter | Biotech Hunter